ASPEN PHAR.UN.ADR /1 O.N. (LDZU F) stock market data APIs
€5.5103
0(0%)
as of July 3, 2025
Try our APIs with
free plan!
ASPEN PHAR.UN.ADR /1 O.N. Financial Data Overview
Price chart is built with
Anychart
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Prev. Close
5.5103
Open
5.5103
High
5.5103
Low
5.5103
52 wk Range
5-12.3254
Market Cap
2 542 M
P/E Ratio
11.3265
Shares Outstanding
444 M
Revenue
45 525 M
Dividends (Yield)
0.0346
Beta
0.432
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ASPEN PHAR.UN.ADR /1 O.N. data using free add-ons & libraries
Get ASPEN PHAR.UN.ADR /1 O.N. Fundamental Data
ASPEN PHAR.UN.ADR /1 O.N. Fundamental data includes:
- Net Revenue: 45 525 M
- EBITDA: 10 792 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ASPEN PHAR.UN.ADR /1 O.N. News
New
Aspen Pharmacare Holdings Ltd (APNHY) (H1 2025) Earnings Call Highlights: Strong Growth Amid ...
Revenue Growth: 9% increase in constant currency, 4% in reported currency. Normalized EBITDA: Up 21% in constant exchange rate (CER), 12% in reported currency. Gross Margin: Growth above 20%. Normaliz...
Investors in Aspen Pharmacare Holdings (JSE:APN) have seen impressive returns of 144% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For exa...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
